A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
Conditions: Obesity; Diabetes Mellitus, Type 2 Interventions: Drug: JNJ-64565111 Dose Level 1; Drug: JNJ-64565111 Dose Level 2; Drug: JNJ-64565111 Dose Level 3; Drug: Placebo Sponsor: Janssen Research & Development, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity | Study